|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45.13 USD | -2.67% |
|
-6.04% | -23.01% |
| Dec. 10 | Wolfe Research Upgrades Bruker to Outperform From Peer Perform, $60 Price Target | MT |
| Dec. 10 | Bruker Receives $25 Million in European Orders for High-Performance Magnetic Resonance Systems | MT |
Business description: Bruker Corporation
Number of employees: 11,396
Sales by Activity: Bruker Corporation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
BSI Nano | 556M | 698M | 787M | 942M | 1.1B |
BSI CALID | - | - | 822M | 960M | 1.09B |
BSI Bio Spin | - | - | 697M | 798M | 906M |
BSI Life Science | 1.25B | 1.51B | - | - | - |
Bruker Energy & Supercon Technologies (BEST) | 190M | 224M | 237M | 281M | 283M |
Eliminations | -12M | -14M | -12.3M | -17M | -14.1M |
Geographical breakdown of sales: Bruker Corporation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
United States | 456M | 601M | 696M | 778M | 938M |
Europe Excluding Germany | 520M | 658M | 592M | 700M | 873M |
Asia Pacific Excluding China | - | - | 408M | 461M | 518M |
China | - | - | 396M | 528M | 471M |
Germany | 245M | 263M | 247M | 282M | 311M |
Other | 138M | 167M | 190M | 217M | 254M |
Asia Pacific | 629M | 729M | - | - | - |
Executive Committee: Bruker Corporation
| Manager | Title | Age | Since |
|---|---|---|---|
Frank Laukien
CEO | Chief Executive Officer | 65 | 1991-01-31 |
Gerald Herman
DFI | Director of Finance/CFO | 67 | 2018-03-16 |
Thomas Bures
AUD | Comptroller/Controller/Auditor | 50 | 2025-01-12 |
Joseph Alldredge
LAW | General Counsel | - | 2022-01-15 |
Falko Busse
PRN | Corporate Officer/Principal | 58 | 2018-04-30 |
Composition of the Board of Directors: Bruker Corporation
| Director | Title | Age | Since |
|---|---|---|---|
William Linton
BRD | Director/Board Member | 78 | 2000-01-31 |
Frank Laukien
CHM | Chairman | 65 | 1991-01-31 |
Richard Packer
BRD | Director/Board Member | 67 | 2007-04-30 |
Hermann Requardt
BRD | Director/Board Member | 70 | 2015-08-05 |
John Ornell
BRD | Director/Board Member | 67 | 2015-08-18 |
Robert Rosenthal
BRD | Director/Board Member | 68 | 2015-11-10 |
Cynthia Friend
BRD | Director/Board Member | 70 | 2016-05-19 |
Adelene Perkins
BRD | Director/Board Member | 65 | 2016-12-31 |
Bonnie Anderson
BRD | Director/Board Member | 67 | 2020-09-02 |
Laura Francis
BRD | Director/Board Member | 58 | 2025-02-17 |
Company details: Bruker Corporation
Group companies: Bruker Corporation
| Name | Category and Sector |
|---|---|
Bruker (Malaysia) Sdn. Bhd.
 Bruker (Malaysia) Sdn. Bhd. Medical SpecialtiesHealth Technology Designs, manufactures, assembles and tests analytical scientific instruments & provides logistics and warehousing services |
Medical Specialties
|
Bruker (Malaysia) Sdn. Bhd.
Bruker (Malaysia) Sdn. Bhd. Medical SpecialtiesHealth Technology Designs, manufactures, assembles and tests analytical scientific instruments & provides logistics and warehousing services |
Medical Specialties
|
Bruker India Scientific Pvt Ltd.
 Bruker India Scientific Pvt Ltd. Manufactures medical appliances and instruments | |
Bruker India Scientific Pvt Ltd.
Bruker India Scientific Pvt Ltd. Manufactures medical appliances and instruments | |
RI Research Instruments GmbH
 RI Research Instruments GmbH Telecommunications EquipmentElectronic Technology Manufactures and develops normal and superconducting radio frequency cavities and systems |
Telecommunications Equipment
|
Other Advanced Medical Equipment & Technology
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.67% | -6.04% | -22.88% | -31.94% | 6.86B | |
| -1.14% | -0.09% | +9.01% | +0.82% | 215B | |
| -0.92% | -5.74% | -0.44% | +98.04% | 192B | |
| -2.60% | +0.04% | -3.48% | -17.24% | 160B | |
| +0.90% | -5.07% | +2.39% | +96.44% | 137B | |
| +0.98% | +1.33% | -18.05% | -12.42% | 57.67B | |
| -1.38% | -3.61% | +12.32% | +10.30% | 48.21B | |
| -2.23% | -3.99% | -0.87% | -10.08% | 39.54B | |
| -2.43% | -1.76% | +2.85% | - | 38.25B | |
| -0.05% | -1.67% | +4.02% | +14.20% | 36.77B | |
| Average | -1.15% | -2.66% | -1.51% | +16.46% | 93.17B | |
| Weighted average by Cap. | -0.99% | -2.40% | +1.33% | +32.67% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BRKR Stock
- Company Bruker Corporation
Select your edition
All financial news and data tailored to specific country editions
